Pain treatment in post-traumatic hip fracture in the elderly: regional block vs. systemic non-steroidal analgesics by Monzón, Daniel Godoy et al.
ORIGINAL RESEARCH ARTICLE
Pain treatment in post-traumatic hip fracture
in the elderly: regional block vs. systemic non-
steroidal analgesics
Daniel Godoy Monzón & Jorge Vazquez &
José R. Jauregui & Kenneth V. Iserson
Received: 20 January 2010 /Accepted: 1 September 2010 /Published online: 6 November 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract
Background This prospective, randomized double-blind
study, conducted over 19 months in a tertiary care ED,
sought to determine if a fascia-iliaca regional anesthetic
block provides better and safer pain relief than does
parenteral analgesia.
Aims This study also aimed to determine the effectiveness
of parenteral NSAID analgesia for acute hip fractures.
Methods Patients >65 years old presenting at an adult ED
with acute hip fractures were randomized upon presentation
to the ED into two groups (A and B) using numbers
generated by the EPI-INFO™ (Atlanta, GA: Centers for
Disease Control and Prevention) program. The randomiza-
tion list was kept by one of the authors who did not interact
with the patients. Two groups of patients were to receive
either (A) a fascia-iliaca block with bupivacaine and
parenteral saline injection, or (B) the same block with
saline and an IV NSAID injection. Upon admission to the
study, vital signs such as blood pressure, mean blood
pressure (MAP), heart rate (HR), respiratory rate (RR) and
pain-intensity measurements [using the Visual Analogue
Scale (VAS)] were obtained and repeated at 15 min, 2 h and
at8 h. The occurrence of complications was registered.
Results One hundred seventy-five patients were randomized,
and 21 were excluded from participation. The remaining 154
patients weregrouped as: group A (n=62) orgroup B (n=92).
The mean pain level on admission to the ED for all patients,
assessed with the VAS, was 8.21±0.91 (CI 95%: 6.43–9.99);
in group A the VAS was 7.6±0.22 and in group B 8.5±0.72
(p=0.411).At15-minevaluation,valueswere:groupA6.24±
0.17and group B 2.9±0.16(p<0.001).Atthe 2-h assessment,
values were: group A 1.78±0.11 and group B 2.3±1.16 (p=
0.764). At 8 h the VAS for group A was 2.03±0.12 and for
group B 4.4±0.91 (p=0.083).
Conclusion This study demonstrates that: (1) parenteral
NSAIDs are very effective as analgesics after hip fractures
in elderly patients, (2) fascia-iliaca regional blocks are
nearly as effective for up to about 8 h after administration
and (3) regional fascia-iliaca blocks effectively control
post-hip fracture pain. (4) Fascia iliaca regional block has a
rapid onset.
Keywords Analgesia.Hip fracture.Geriatrics.Iliofascial
block.Fascia-iliaca block.Non-steroidal analgesics.
Regional block.Emergency medicine
Introduction
Background
In the US, hip fracture is a common event, especially in the
elderly. The incidence of hip fractures is 517 fractures/
100,000 person-years, with about 76% occurring in women
[1]. Hip fracture rates increase exponentially with age in
both men and women [2]. People ≥85 years old are from 10
to 15 times more likely to sustain hip fractures than are
people aged 60 to 65 years [3]. In 1997, treatment-
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Miller reported that the seriousness of hip fractures to
overall patient health is reflected in these patients’ 16-day
mean hospital stay, an in-hospital mortality of 5% and a 3-
month mortality of 10% [5].
Inadequate pain relief contributes to delayed recovery
from hip fractures [6]. Opiates often have unforeseeable
neurological effects in the elderly because of the high
prevalence of pre-existing cognitive deficits and vascular
neurological disorders. Opiates also cause severe constipa-
tion and nausea (vomiting, when associated with neurolog-
ical deficit, may lead to life-threatening aspiration
pneumonia). In addition, opiates may potentially have
harmful cardiovascular and respiratory effects.
To help lessen such complications, the standard of care
in many parts of the world is to use parenteral non-steroidal
anti-inflammatory drugs (NSAIDs) instead of narcotics as
the first-line analgesic in patients with hip fracture. On the
other hand, NSAIDs predispose patients to gastrointestinal
bleeding, consequently increasing anemia and raising the
number of transfusions; this too can cause various kinds of
renal damage and refractory hypertension [7].
An alternative to avoid the above-mentioned systemic
complications of both opioids and NSAIDs is to control
pain using a regional block. Two such blocks, the femoral
block and the fascia-iliaca (iliofascial) block, are often used
to control postoperative pain. The fascia-iliaca (iliofascial)
block has been shown to be easy and safe to use in the ED
[9]. This block also avoids the complications of the more
common femoral block (prolonged motor block, inadver-
tent arterial puncture, direct nerve damage) [7–9]. While it
can be used to control postoperative pain, ED management
is concerned with preoperative analgesia.
Goals of this investigation
This study aimed to determine if a fascia-iliaca regional
anesthetic block provides better and safer pain relief than
does parenteral NSAID analgesia, and whether parenteral
NSAIDs are effective analgesics in these situations.
Material and methods
Setting
This prospective randomized double-blind, cross-sectional
study was performed during a 19-month period (June 2006
to January 2008) in the ED of a tertiary referral center. The
ED has a residency program with 120,000 consultations a
year. The study was approved by the institution’s teaching
and research committee.
Study design
For calculation of the sample size, a difference of 2 ± 0.8
points in the VAS scale is considered clinically significant.
To detect differences in the rate of adverse effects between
groups, considering a 30% incidence in group A vs. a
possible 10% incidence in group B with the same error
levels, 62 patients were required without continuity
correction, and 72 patients were required for Fisher's exact
test.
As soon as the diagnosis of hip fracture was made and
before an analgesic was administered, the patient or their
legal decision-maker was informed about the study. If they
agreed to participate, they signed an informed consent
form.
Patients were randomized into two groups (A and B)
using numbers generated by the EPI-INFO™ (Atlanta, GA:
Centers for Disease Control and Prevention) program. The
randomization list was kept by one of the authors who did
not interact with the patients. He gave instructions to the
patient’s ED nurse about which treatment should be
administered. The nurse prepared the medication following
the physician’s instructions and assigned a letter to the
protocol (from a set of 10 letters, 5 for group A and 5 for
group B) that designated whether the patient was receiving
active medications in the fascia-iliaca block. The physician
administering the medications and obtaining the VAS
scores did not know which medications the patient was
receiving.
Selection of participants
Our patient pool consisted of adult patients more than 65
years old who presented to the ED because of a previously
undiagnosed and untreated hip fracture.
Exclusion criteria for the study included anatomical
abnormalities in the inguinal area different from fracture,
known coagulation disorders, a history of allergy to any of
the active ingredients used during the study and refusal to
participate.
Patient measurements
The protocol included observing patients for 8 h. Upon
admission to the study, vital signs such as blood pressure,
mean blood pressure (MAP), heart rate (HR), respiratory
rate (RR) and pain-intensity measurements [using the
Visual Analogue Scale (VAS)] were obtained. Vital signs
and VAS-based pain measurement evaluations were per-
formed at 15 min, 2 h and 8 h. (Vital signs were also taken
at intermediate times for clinical purposes.) The occurrence
of adverse effects or complications was concomitantly
evaluated in all patients.
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A peripheral IV was placed in all patients for the
administration of analgesia and hydration. A single fascia-
iliaca compartment block [9–11] was performed on all
patients with either 0.9 normal saline (group A) or 0.3 ml/kg
0.25% bupivacaine (group B). Patients in group A received
IV NSAID analgesics (Diclofenac or Ketorolac, depending
on their medical history), whereas those in group B had 3 ml
to 5 ml 5% dextrose administered IV.
A fascia-iliaca block is performed by identifying the
inguinal ligament and the femoral artery. A 21-g, 2-inch
intramuscular injection needle is inserted perpendicular to
the skin at a point 1 cm below the juncture of the lateral and
medial two-thirds of a line that joins the pubic tubercle to
the anterior superior iliac spine. The needle is inserted until
a loss of resistance is felt as the fascia lata is passed, and
then further advanced until a second loss of resistance
occurs when the fascia iliaca is pierced (often described as
two “pops”)[ 9]. After aspirating to assure that the needle is
not in a vessel, solution is injected.
Outcome measures
The primary measurement used was VAS to determine pain
scores in the two groups. The patients’ vital signs over the
course of the study period were used as secondary
measurements.
Primary data analysis
The general characteristics of the entire study sample and of
each subgroup were calculated for mean age, sex, co-
morbidities, vital signs and VAS. Quantitative data were
reported as mean ± standard error regardless of the
distribution of the variables. Variables such as sex,
prevalence of co-morbidities and side of fracture were
dichotomized into present or absent.
Baseline VAS scale values and vital sign data were
compared to data obtained at 15 min, 2 h and 8 h in an
independent manner. The Student’s t-test for paired samples
was used for these continuous quantitative values. When
the same values were compared between groups A and B,
the Student’s t-test was used for each comparison at 15 min,
2 and 8 h, and an ANOVA curve was used for sequential
comparison. Complications such as vomiting, nausea and
hematoma at the injection site were dichotomized as present
or absent, and were compared at 8 h using Fisher’s exact
test. For statistical inference, a type I error of 0.05 and a
power of 80% was assumed.
The statistical analysis was performed using the Primer
of Biostatistics 4.0 software (McGraw Hill, 1996) and the
Statistix 7.0 analytical software (2000).
Results
Characteristics of study subjects
One hundred seventy-five patients were randomized upon
presentation to the ED. A total of 21 were excluded from
participation (1) because they or their legal decision-maker
declined to participate, (2) due to systemic or laboratory
abnormalities that interfered with their participation or (3)
because they were subsequently found to have missing data
(VAS not recorded or incomplete vital signs on scheduled
measurements). The remaining 154 patients already had
been randomly assigned to either group A (saline blocks
with parenteral treatment for pain; n=62) or group B
(bupivacaine blocks; n=92).
The demographic characteristics and baseline clinical
statusofthe studypatientsare showninTable1. No statistical
differences were found between the two study groups or
between the initial two groups chosen before patients were
eliminated from the study. Aside from the hip fracture, the
most common additional clinical conditions found in the
study patients were hypertension, diabetes, anemia, cancer,
ischemic heart disease and chronic cognitive impairment at
different stages. Of all these patients, 130 (85%) had more
than one concomitant condition. The mean pain level on
admission to the ED for all patients, as assessed with the
VAS, was 8.21±0.91 (CI 95%: 6.43–9.99); this is catego-
rized as severe pain. There were no patients who described a
maximal pain level (10 points): admission pain levels ranged
from 5 to 9 in group A and 4 to 9 in group B.
Main results
Table 2 describes patient VAS and autonomic responses to
the two analgesic interventions over the 8-h study period.
Despite the difference in the final number of patients in the
two study groups, there were no statistically significant
differences between their demographic characteristics or
their baseline parameters.
Patient pain assessment showed that while both the
parenteral NSAID group (A) and the fascia-iliaca block (B)
group demonstrated a significant analgesic effect, the paren-
teral block was much more effective at 15 min (p=0.001),
although both groups showed significant analgesia effects
compared to baseline. At 2 h, analgesia effectiveness was
statistically similar in both groups (p = 0.764).
Analgesic effects were maintained in both groups at 8 h,
although at 8 h, pain intensity was somewhat higher in group
B than in group A. The difference at 8 h, however, was not
statistically significant (p=0.083).
The autonomic parameters measured during the study
(heart rate, respiratory rate, mean blood pressure) showed
that they paralleled the VAS findings.
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During the 8-h study period, some clinical derangements
were seen beginning at 2 h after analgesic administration.
They markedly diminished by 8 h.
The overall incidence of adverse effects during the
s t u d yp e r i o dw a s0 . 1 7 7( 1 1 / 6 2p a t i e n t s )f o rg r o u pAa n d
0.032 (3/92 patients) for group B. In group A, there were
four episodes of delirium, two of nausea, and two of
nausea and vomiting. It was unclear if these had any
relation to the medication administration. Three local
bruises occurred at the site of injection of the placebo
(group A). In group B, the only complications were local
bruises at the site of injection.
Including all the adverse events, the difference-in-
proportions test was significant (p=0.005) between the
two groups.
Limitations
Due to a randomization before enrollment, the number of
patients in the two study groups was dissimilar. Neverthe-
less, there were no statistical differences between either
their demographics or their baseline clinical parameters.
Since the treating nurse was aware of the randomization
group, it is possible that s/he could have biased the patient
or the treating provider, consciously or otherwise. The
sample size was calculated on the basis of complications
only. Distracting injuries were not recorded.
Discussion
Good emergency care requires early and effective manage-
ment of hip fracture pain. In this study, we found that
fascia-iliaca blocks seem to provide at least equivalent
relief to patients without causing unwanted and potentially
deleterious side effects.
The lack of maximum pain scores in the study
population may have been because of the high prevalence
of co-morbidities observed in the study group. It could be
that the patients had previously experienced more intense
pain than that from the hip fracture or that their pain was
attenuated by the peripheral or even central neurological
disorders (convergence phenomenon) of the co-morbidities
and by age. These underlying medical conditions may have
also caused the falls that resulted in the patients’ fractures,
an association clearly established in the literature [1].
When administering parenteral analgesics to patients
with hip fractures, we follow the practice standard used
throughout Argentina: that is, first to administer parenteral
NSAIDs, and, if the pain does not lessen substantially,
opioids are given. While none of our study patients rated
their pain intensity as a VAS score of 10 (maximum
tolerable pain), values above 8 generally indicate that
Table 2 Patient VAS and autonomic responses to the two analgesic interventions over the 8-h study period
Baseline 15 min 2 h 8 h
A B P VALUE A B P VALUE A B P VALUE A B P VALUE
VAS 7.6 ± 0.22 8.5±0.72 0.411 NS 6.24±017 2.9 ±0.16 <0.001 1.78±011 2.3 ±1.16 0.764 2.03±0.12 4.4±0.91 0.083 NS
HR 119.5±2.5 113.1±3.5 0.268 NS 118.2±2.4 111.2±2.3 0.096 NS 88.7±1.8 82.4±1.1 0.01 79.2±1.2 85.3±1.2 0.005
RR 21.2±0.65 23±1.10 0.532 NS 20.4±0.52 22.4 ± 0.33 0.006 19.2 ± 0.44 20.8 ± 0.56 0.091 NS 18.9±0.38 19.1±0.23 0.696 NS
MAP 110±1.5 108±1.90 0.282 NS 112 ± 1.4 112±1.6 1 NS 109±1.4 110±1.2 0.66 NS 110±1.5 109±1.4 0.697 NS
Group A Group B Significance (p)
N6 2 9 2 —————
Median age (years) 79.4±3.38 73.5±3.29 0.322 (NS)
Males 25 (40%) 33 (35%) 0.645 (NS)
Prevalence of comorbidities 55 (89%) 83 (90%) 0.304 (NS)
Mean VAS 7.60±0.22 8.5±0.72 0.411 (NS)
GCS≤14 1 (2%) 2 (2%) 0.557 (NS)
Mean HR 119.5±2.48 113.1±3.5 0.268 (NS)
Mean MAP (mmHg) 110±1.5 108±1.9 0.532 (NS)
Mean? RR 21.2±0.65 23.1±1.1 0.282 (NS)
Table 1 Comparison of the two
patient groups
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need to use opioids because of the reduction of pain levels
obtained with the fascia iliaca block.
Fascia-iliaca blocks, a routine practice in our ED, are
easily learned, much safer than the commonly used femoral
blocks and well-tolerated [9]. They can be done with
commonly available equipment and should be part of all
emergency physicians’ skill sets.
An analgesic effect from both interventions was
evident at 15 min, although it was much more significant
in group B (regional block). By 2 h after administration,
both groups had achieved similar pain relief, but at 8 h,
the block’s effects were wearing off. The change in
patients’ autonomic responses to pain generally followed
their reported pain levels. No clinical complications
attributed to either of the analgesic agents were observed
during this period.
Further study is needed to evaluate the possible synergic
activity of NSAIDs and fascia iliaca block in pain
management for patients with hip fracture.
Conclusions
This study demonstrates that: (1) parenteral NSAIDs are
very effective as analgesics after hip fractures in elderly
patients, (2) fascia-iliaca regional blocks are nearly as
effective for up to about 8 h after administration, and (3)
regional fascia-iliaca blocks effectively control post-hip
fracture pain—without narcotics’ deleterious side effects.
(4) In the ED, by significantly reducing pain, fascia-iliaca
regional blocks can permit more rapid assessment and
diagnostic procedures in the ED.
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